Status:
COMPLETED
Establishment of a Non-invasive and Indirect Measure of Volitional Pimax
Lead Sponsor:
Centre d'Investigation Clinique et Technologique 805
Conditions:
Neuromuscular Diseases
Respiratory Failure
Eligibility:
All Genders
6+ years
Brief Summary
Respiratory failure is the main death cause in muscular diseases. Non-invasive and volitional measures of inspiratory muscles strength include the nasal pressure with an occluded nostril and the maxim...
Eligibility Criteria
Inclusion
- Neuromuscular disease
- Pimax evaluation indication
Exclusion
- pregnant women
- usual contre-indications for nuclear magnetic resonance
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT02242162
Start Date
May 1 2009
End Date
January 1 2016
Last Update
March 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital R Poincaré
Garches, France, 92380